Becton Dickinson & Co. is recalling 162 units of BD Synapsys Informatics Solution software versions 4.20, 4.30, 5.10, 5.20, and 5.30 due to a software error in the in-line breakpoint feature. The software may incorrectly display antibiotic sensitivity results for certain organisms that do not have defined standards, potentially leading to false susceptible or false resistant reports. This defect can result in patients receiving ineffective antibiotic treatments or being denied preferred therapies. Consumers should contact their healthcare provider or Becton Dickinson & Co. to ensure their laboratory software is updated or patched to correct this error.
The software error can cause medical professionals to misinterpret how effective an antibiotic will be against an infection. This may lead to the use of an ineffective drug (false susceptible) or the unnecessary avoidance of a preferred treatment (false resistant), which can cause inadequate treatment or prolonged illness.
Software update or patch
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.